-
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
Monday, October 2, 2023 - 9:49am | 589MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dispute, for a total consideration value of $9 million. On January 24, 2020, MediPharm Labs filed a statement of claim in...